| JXSB2500041 | DS-1062a | datopotamab deruxtecan | Injection | Biological Products(1) | Supplementary Application | 2025-05-17 | | Daiichi Sankyo Co Ltd;Baxter Oncology GmbH | | | view |
| JXSL2500054 | DS-1062a | datopotamab deruxtecan | Injection | Biological Products(1) | Import Drug Application | 2025-04-08 | | AstraZeneca AB;Astrazeneca Investment (China) Co Ltd | | | view |
| JXSL2500045 | DS-1062a | datopotamab deruxtecan | Injection | Biological Products(1) | Import Drug Application | 2025-03-26 | | AstraZeneca AB;Astrazeneca Investment (China) Co Ltd | | | view |
| JXSB2400181 | DS-1062a | datopotamab deruxtecan | Injection | Biological Products(1) | Supplementary Application | 2024-12-28 | | AstraZeneca AB;Baxter Oncology GmbH | | | view |
| JXSL2400231 | DS-1062a | datopotamab deruxtecan | Injection | Biological Products(1) | Import Drug Application | 2024-11-28 | | Daiichi Sankyo Co Ltd | | | view |
| JXSL2400171 | DS-1062a | datopotamab deruxtecan | Injection | Biological Products(1) | Import Drug Application | 2024-09-15 | | AstraZeneca AB;Astrazeneca Investment (China) Co Ltd | | | view |
| JXSB2400090 | DS-1062a | datopotamab deruxtecan | Injection | Biological Products(1) | Supplementary Application | 2024-07-05 | | Daiichi Sankyo Co Ltd;Baxter Oncology GmbH | | | view |
| JXSL2400117 | DS-1062a | datopotamab deruxtecan | Injection | Biological Products(1) | Import Drug Application | 2024-06-27 | | AstraZeneca AB;Astrazeneca Investment (China) Co Ltd | | | view |
| JXSB2400070 | DS-1062a | datopotamab deruxtecan | Injection | Biological Products(1) | Supplementary Application | 2024-06-05 | | Daiichi Sankyo Co Ltd;Baxter Oncology GmbH | | | view |
| JXSB2400042 | DS-1062a | datopotamab deruxtecan | Injection | Biological Products(1) | Supplementary Application | 2024-04-22 | | Daiichi Sankyo Co Ltd;Baxter Oncology GmbH | | | view |
| JXSB2400003 | DS-1062a | datopotamab deruxtecan | Injection | Biological Products(1) | Supplementary Application | 2024-01-16 | | AstraZeneca AB;Baxter Oncology GmbH | | | view |
| JXSL2300232 | DS-1062a | datopotamab deruxtecan | Injection | Biological Products(1) | Import Drug Application | 2023-12-22 | | Daiichi Sankyo Co Ltd;Astrazeneca Investment (China) Co Ltd | | | view |
| JXSL2300173 | DS-1062a | datopotamab deruxtecan | Injection | Biological Products(1) | Import Drug Application | 2023-10-09 | | Daiichi Sankyo Co Ltd;Astrazeneca Investment (China) Co Ltd | | | view |
| JXSB2300083 | DS-1062a | datopotamab deruxtecan | Injection | Biological Products(1) | Supplementary Application | 2023-07-04 | | Daiichi Sankyo Co Ltd;Baxter Oncology GmbH | | | view |
| JXSL2300051 | DS-1062a | datopotamab deruxtecan | Injection | Biological Products(1) | Import Drug Application | 2023-03-14 | | Daiichi Sankyo Co Ltd;Astrazeneca Investment (China) Co Ltd | | | view |
| JTS2300008 | 注射用Datopotamab deruxtecan (DS-1062a) 100mg | datopotamab deruxtecan | Injection | Biological Products | Disposable Import Drug Application | 2023-03-10 | | Baxter Oncology GmbH;Daiichi Sankyo Europe GmbH;Daiichi Sankyo (CHINA) HOLDINGS Co Ltd | | | view |
| JTS2300009 | Datopotamab deruxtecan (DS-1062a)原液 | datopotamab deruxtecan | Active ingredient | Biological Products | Disposable Import Drug Application | 2023-03-10 | | Daiichi Sankyo Chemical Pharma Co Ltd Onahama Plant;Daiichi Sankyo Europe GmbH;Daiichi Sankyo (CHINA) HOLDINGS Co Ltd | | | view |
| JXSL2200174 | DS-1062a | datopotamab deruxtecan | Injection | Biological Products(1) | Import Drug Application | 2022-09-30 | | AstraZeneca AB;Astrazeneca Investment (China) Co Ltd | | | view |
| JXSL2200166 | DS-1062a | datopotamab deruxtecan | Injection | Biological Products(1) | Import Drug Application | 2022-09-16 | | Daiichi Sankyo Co Ltd;Astrazeneca Investment (China) Co Ltd | | | view |
| JXSL2200156 | DS-1062a | datopotamab deruxtecan | Injection | Biological Products(1) | Import Drug Application | 2022-09-08 | | First Pharmaceutical (China) Co Ltd;Daiichi Sankyo Co Ltd | | | view |
